RNA editing therapies
Scope
Date
~
-
Bio & Pharma
GI Innovation seeks to license allergy therapy to Japan in 2023
South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...
Jul 17, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's ToolGen develops gene-edited cow for artificial blood
South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...
Jun 21, 2023 (Gmt+09:00)
-
Electronics
Samsung launches collaborative product with illustrator Max Dalton
Samsung Electronics Co. announced on Monday that it has unveiled a special edition of Bespoke Jet Bot AI, collaborative with illustrator Max Dalton,...
Jun 19, 2023 (Gmt+09:00)
-
Korean food
Kooksoondang to export limited edition makgeolli to Japan in four years
Kooksoondang Co., a South Korean brewery that produces traditional rice-based wines, announced on Friday that it will export 100,000 bottles of the ...
Jun 16, 2023 (Gmt+09:00)
-
Retail
Breitling launches 2nd Korea limited edition watch in 2023
Breitling, a luxury Swiss watchmaker, has launched a limited edition of one of its flagship models, the Chronomat B01 24, in South Korea, marking th...
Jun 02, 2023 (Gmt+09:00)
-
Artificial intelligence
Neurophet strives to be first mover in fight against Alzheimer’s
Neurophet Inc., a South Korean startup developing artificial intelligence-powered medical solutions for brain diseases, is striving to make a breakt...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Welt gets second digital therapeutic device approval in S. Korea
South Korea's Ministry of Food and Drug Safety announced on Wednesday that it has approved the cognitive therapy software "WELT-I" developed by We...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Verismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
Apr 07, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Budget Galaxy A34 5G to be released in domestic market
Samsung Electronics Co. announced on Thursday that it will release the budget smartphone Galaxy A34 5G in the domestic market starting tomorrow.The ...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q
NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...
Mar 24, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korea's Hancom to apply ChatGPT to Hancom Docs
South Korea's office software developer Hancom Inc. will apply ChatGPT, a generative artificial intelligence (AI) service that allows users to reque...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Mar 03, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor unveils new Creta at Indonesia motor show
Hyundai Motor Co., South Korea’s largest automaker, introduced a new version of its Creta compact SUV at the Indonesia International Motor Sho...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Airlines
T'way Air completes IOSA recertification process
South Korea's low-cost carrier T'way Air Co. said on Monday that it has completed the IATA Operational Safety Audit (IOSA) recertification from the ...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Korean startups
Kream poised to become unicorn after closing $157 mn Series C round
Kream, a customer-to-customer (C2C) platform for buying and selling limited-edition sneakers, is slated to close the Series C round with a 200 bil...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Logistics
Hyundai Glovis joins hands with Lion Group to move into Malaysian logistics market (edited)
Hyundai Glovis will enter the Southeast Asian logistics market in partnership with a large Malaysian company. The company, Hyundai Motor Group's log...
Nov 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Korean teens prefer TikTok over KakaoTalk, says survey
South Korean teens appear to prefer to do their social networking on TikTok over KakaoTalk, as short-form videos surge in popularity worldwide. ...
Aug 26, 2022 (Gmt+09:00)
-
Arts
Corporate sponsors focus on luxury at Seoul's first Frieze Art Fair
With just three days before the world-renowned Frieze Art Fair launches its inaugural event in Seoul, corporate sponsors are duking it out to outs...
Aug 26, 2022 (Gmt+09:00)
-
Bio & Pharma
K-bio firms embrace gene therapy CDMO as Samsung looks the other way
South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...
Aug 05, 2022 (Gmt+09:00)
-
Artificial intelligence
AI-powered translation startup XL8 raises $2.7 million in bridge investment
Artificial intelligence-powered translation startup XL8 Inc. said on Monday it raised 3.6 billion won ($2.7 million) in a bridge round prior to Seri...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
Latest News
- 1 S.Korea’s Naver to launch Silicon Valley venture arm in aggressive AI push
- 2 UK chip testing device maker TeraView seeks Kosdaq debut
- 3 K-Beauty defies seasonal slump with record $980 mn in April exports
- 4 Samsung flexes financial muscle as insurance, card units top sector rankings
- 5 Greystar hires ex-Samsung SRA manager to launch Seoul office